Frost & Sullivan Recognizes IMO's Medical Terminology Platform for Enabling the Clearest Patient Narrative

USA - English

• India - English

"Recording data in clinical information systems using standardized healthcare codes is crucial to obtain payment for clinical care and meet regulatory requirements, but varying standards and lack of specific codes can lead to inaccurate medical records, repeat testing, delayed diagnosis or incorrect treatment," said Frost & Sullivan Senior Consultant Jennifer Marks. "IMO provides a suite of clinical interface terminology solutions that link clinician-friendly language to codes from standardized administrative and reference healthcare terminologies, enabling a clear patient narrative and enhanced communication across healthcare institutions."

IMO's primary offerings, IMO® Problem (IT) Terminology and IMO® Procedure (IT) Terminology, enhance customer accessibility and the granularity of codes offered. The basis of the lexical mappings relies on medical concepts, customer feedback, and industry need—providing relevant, easily utilized, actionable codes that preserve clinical intent.

The company also offers a Medication (IT) Terminology solution to check for allergies, drug-interactions, contraindications, and maximum dosing of drugs for specific patients. Further, its iHealth Search® application brings medical content and sites to providers, while the Medical Necessity solution alerts providers when a test is not a treatment necessity.

"IMO chooses to map each IMO lexical term directly to codes by creating a unique lexical ID that maps to the appropriate reimbursement code set," noted Marks. "This future-proof curation process ensures core term preservation for future reimbursement codes releases, allowing IMO to integrate the new code systems into its platform without having to reprogram multiple levels of the platform."

Further, IMO maintains close customer interaction to ensure the highest-quality solutions. For instance, customers can use the IMO Intelligent Service Desk to submit lexical terms they wish to use in a different manner. If the new term passes a stringent editorial review, it is released to all customers. This awareness of customer needs and the desire to provide optimal value for both current and future products has led to a client base that accounts for over 75 percent of providers in the United States.

IMO's future focus extends to using Big Data to solve small problems, specifically unstructured texts and series of health notes. The platform identifies and scans such text entries to pull different terms and group them into specific categories, ensuring higher customer usability in electric health records. It simultaneously enhances its own lexical terminology. The company also focuses on partnering with organizations that have aligned and advanced curation methodologies, and coding of content and unstructured text.

"By tackling multiple small problems, IMO enacts granular changes that aid incremental expansion while maintaining its internal vision," said Marks. "The company's global commercial capabilities with some of the largest organizations also mean that it can help educate developing markets in specific use cases to enhance IMO products' usability worldwide."

For its outstanding products that support clinician efforts to deliver superior patient care, IMO is the worthy recipient of the Frost & Sullivan Product Leadership Award in the medical terminology services market. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Intelligent Medical Objects, Inc.

Intelligent Medical Objects, Inc., (IMO) is the developer of the most widely-accepted medical terminology solution for the management of medical vocabularies and software applications at healthcare organizations worldwide. IMO's terminology is used by more than 3,500 hospitals and 450,000 physicians daily, and this trusted terminology platform supports innovations by provider systems. IMO medical vocabulary and mapping products effectively capture clinical intent and help EMRs preserve and communicate this across the entire spectrum of care. IMO clinical terms are mapped to all standard coding systems including  ICD-9, ICD-10 and SNOMED®, The accuracy of IMO's interface terminology was found to be "nearly perfect" in an independent study published by the US Centers for Disease Control. Read more at www.e-imo.com. Follow @IMOSolutions on Twitter.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: [email protected]

IMO Press Contact:
David Haines, MBA
P: 847-272-1242
E: [email protected]

Logo - http://photos.prnewswire.com/prnh/20160513/367391

SOURCE Frost & Sullivan

Related Links

http://www.frost.com